Vita Life Sciences Ltd
ASX:VLS

Watchlist Manager
Vita Life Sciences Ltd Logo
Vita Life Sciences Ltd
ASX:VLS
Watchlist
Price: 2.15 AUD 2.38% Market Closed
Market Cap: 121.3m AUD
Have any thoughts about
Vita Life Sciences Ltd?
Write Note

Vita Life Sciences Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vita Life Sciences Ltd
Capital Expenditures Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
ALA

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Vita Life Sciences Ltd
ASX:VLS
Capital Expenditures
-AU$583k
CAGR 3-Years
-64%
CAGR 5-Years
-72%
CAGR 10-Years
2%
Mayne Pharma Group Ltd
ASX:MYX
Capital Expenditures
-AU$20.9m
CAGR 3-Years
6%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Capital Expenditures
-AU$25k
CAGR 3-Years
-46%
CAGR 5-Years
-16%
CAGR 10-Years
5%
Botanix Pharmaceuticals Ltd
ASX:BOT
Capital Expenditures
-AU$18m
CAGR 3-Years
-1 195%
CAGR 5-Years
-323%
CAGR 10-Years
N/A
Probiotec Ltd
ASX:PBP
Capital Expenditures
-AU$10.8m
CAGR 3-Years
-47%
CAGR 5-Years
0%
CAGR 10-Years
-5%
Arovella Therapeutics Ltd
ASX:ALA
Capital Expenditures
-AU$129.3k
CAGR 3-Years
37%
CAGR 5-Years
38%
CAGR 10-Years
N/A

See Also

What is Vita Life Sciences Ltd's Capital Expenditures?
Capital Expenditures
-583k AUD

Based on the financial report for Jun 30, 2024, Vita Life Sciences Ltd's Capital Expenditures amounts to -583k AUD.

What is Vita Life Sciences Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
2%

Over the last year, the Capital Expenditures growth was -182%. The average annual Capital Expenditures growth rates for Vita Life Sciences Ltd have been -64% over the past three years , -72% over the past five years , and 2% over the past ten years .

Back to Top